RP
Rapid Micro Biosystems, Inc.
RPID · NASDAQ
$1.11 -4.31% (-$0.05)
1M -28.85%
Market Cap $50.3M
P/E Ratio -
Div. Yield -
ROE 177.04%
Bulios Fair Price
$1.51
36.0% upside
Current Price
$1.11
Undervalued Fair Value Overvalued
According to Bulios Fair Price, RPID is currently undervalued relative to its market price. How does it work?
Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Piotroski F-Score Weak
2/9Valuation
81 /100
Cheap P/B 2.83x
P/S 1.43x
P/FFO N/A
Growth
78 /100
Growing Book val. growth 41.30%
Rev. growth 25.15%
FCF growth N/A
Profitability
1 /100
Weak Op. margin 141.45%
Gross margin 10.03%
FCF margin 114.83%
Quality
8 /100
Poor ROA 87.60%
ROIC 119.67%
Asset turnover 0.60x
Debt
42 /100
Moderate Int. coverage -19.36x
Debt/Equity 1.32x
Current ratio 2.55x
Stability
71 /100
Stable EPS volatility 6.16%
Beta 1.44x
Profitable years 0
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about RPID
Online
Sector
Healthcare
Industry
Medical - Devices
CEO
Robert G. Spignesi Jr.
Employees
171
Headquarters
Lexington
Upcoming events
06 NOV
Earnings
Upcoming earnings report